Roth Capital Resumes BioLineRx (BLRX) at Buy
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Price: $2.67 -0.74%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Roth Capital resumed coverage on BioLineRx (NASDAQ: BLRX) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on BioLineRx click here. For more ratings news on BioLineRx click here.
Shares of BioLineRx closed at $2.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jones Trading Starts Xtend AI Robotics (XTND) at Buy
- Barclays Starts Yara International ASA (YAR:NO) (YARIY) at Underweight
- B.Riley Starts Infleqtion, Inc (INFQ) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
